Allergy, asthma, and immunology care provider.
AllerVie Health, a U.S.-based network of allergy, asthma, and immunology specialty clinics headquartered in Frisco, Texas, experienced a ransomware attack on its network between October 24 and November 3, 2025. The company discovered unusual activity on November 2, 2025 and engaged external cybersecurity experts to investigate. The Anubis ransomware group claimed responsibility for the attack on November 26, 2025 by listing AllerVie on its dark-web leak site and publishing samples of stolen medical files.\n\nThe breach affected approximately 169,000 individuals. Confirmed compromised fields in the public disclosure included names, email addresses, phone numbers, street addresses, and Social Security numbers. Public reporting and Anubis's leak-site samples indicated that the underlying data exfiltration also covered medical records, billing documents, internal schedules, insurance information, and diagnostic and treatment information specific to allergy and immunology care. Driver's license and state ID numbers were also identified in the affected dataset for some individuals.\n\nFor affected patients, the practical risk profile combines standard identity-fraud exposure with healthcare-specific risks. The combination of name, address, and Social Security number is a strong base for synthetic identity fraud and fraudulent credit applications. Inclusion in the dataset confirms the existence of an allergy or immunology care relationship, which can support medical-themed scam calls referencing real treatments, billing details, or insurance claims. Affected individuals should accept the credit monitoring offered by AllerVie, freeze credit at all three U.S. bureaus, monitor health-insurance explanation-of-benefits statements for unfamiliar charges, and treat unsolicited contact referencing AllerVie, allergy treatments, or insurance verification with caution.
ObscureIQ assessment: High risk of identity theft and medical fraud. Even where diagnosis data is not explicitly listed in the extracted fields, exposure of SSNs plus healthcare association makes patients vulnerable to billing scams, treatment-themed phishing, and privacy harms.
AllerVie faces significant institutional cost from the incident. Federal HIPAA notification obligations, U.S. Department of Health and Human Services Office for Civil Rights filings, multistate attorney-general filings, and a class-action litigation pipeline are all underway. The Anubis ransomware group's posting of medical-record samples on its leak site adds direct evidence of data exfiltration that strengthens future litigation. AllerVie's specialty position in allergy and immunology care means the patient base includes both adults and pediatric patients, broadening the potential affected population. Operationally, the company reset passwords, notified law enforcement, and reviewed data-protection policies. Reputational damage is concentrated within the Texas and broader U.S. specialty-clinic market.
AllerVie Health is a U.S.-based network of allergy, asthma, and immunology specialty clinics, headquartered in Frisco, Texas. The company operates more than seventy clinic locations across multiple U.S. states, providing services including allergy testing, asthma management, chronic respiratory care, immunotherapy, and related specialty treatments. As a HIPAA-regulated healthcare provider, AllerVie maintains substantial volumes of protected health information including patient identity, contact, insurance, billing, diagnostic, and treatment records, alongside Social Security numbers and other administrative identifiers used for insurance verification and care coordination.
Specialty clinic networks collect patient identity, contact, and insurance-linked records, often including SSNs and other sensitive administrative data tied to care delivery.
AllerVie Health discovered unusual network activity on November 2, 2025 and engaged external cybersecurity experts to investigate. The forensic review concluded on November 24, 2025 and identified the affected fields. The company began notifying affected individuals by mail on December 22, 2025 and disclosed the incident to the New Hampshire Attorney General on December 23, 2025. The Anubis ransomware group claimed responsibility for the attack on November 26, 2025 by listing AllerVie on its dark-web leak site and publishing samples of stolen medical files. AllerVie is offering complimentary credit monitoring and identity-theft protection through Cyberscout, a TransUnion company. Class-action investigations by U.S. plaintiff law firms began in late December 2025.
Field names are shown in full for clarity and search visibility. Canonical machine keys are emitted only in this page’s structured data.
Attribution and method are based on available breach intelligence. Reported attack vector: Ransomware.
If you believe your information may be included:
AllerVie Health, a U.S.-based network of allergy, asthma, and immunology specialty clinics headquartered in Frisco, Texas, experienced a ransomware attack on its network between October 24 and November 3, 2025. The company discovered unusual activity on November 2, 2025 and engaged external…
Verified fields include Email Address, Full Name, Phone Number, Physical Address, Social Security Number.
Change reused passwords, enable MFA, and (if identity or financial data is involved) freeze your credit and monitor your accounts.
Every claim on this page is traceable. This breach draws on:
Enter your email to check whether your data appears in this breach. We’ll send a 6-digit code to confirm it’s your address.
Be the first to know when new breaches are disclosed. Free forever — confirm your email with a 6-digit code.
Executives, public figures, and high-visibility operators can receive tailored exposure intelligence and hardening guidance.
Request Consultation